[Hydroxyethyl starch solutions]

Area of Science:

• Critical Care Medicine
• Pharmacology
• Fluid Resuscitation

Background:

• Hypovolemia is prevalent in surgical, trauma, and ICU patients, often without obvious fluid loss.
• It can result from vasodilation or increased capillary permeability due to endothelial barrier dysfunction.
• Hydroxyethyl starch (HES) solutions are widely used for volume replacement therapy.

Purpose of the Study:

• To review the physical and chemical characteristics of various hydroxyethyl starch solutions.
• To present their pharmacokinetics, metabolism, and elimination routes.
• To discuss their mechanism of action, effects on plasma volume, safety, tolerability, and adverse events.

Main Methods:

• Literature review of hydroxyethyl starch solutions.
• Analysis of product characteristics: molecular weight, concentration, molar substitution, and substitution pattern.
• Evaluation of safety data, including hemostasis, platelet function, pruritus, anaphylactoid reactions, and serum amylase levels.

Main Results:

• Hydroxyethyl starch solutions are synthetic colloids with properties similar to natural colloids.
• Key characteristics influencing their use include molecular weight, concentration, and substitution patterns.
• Safety concerns include potential adverse effects on hemostasis, pruritus, and anaphylactoid reactions.

Conclusions:

• Hydroxyethyl starch solutions are effective for volume replacement but require careful consideration of their properties and potential risks.
• Understanding their pharmacokinetics and safety profile is crucial for optimal patient management.
• Further research may be needed to fully elucidate long-term safety and efficacy in diverse patient populations.